Preclinical models using melanoma cell lines have demonstrated decreased T-cell infiltration in PTEN-silenced tumors and show that loss of PTEN upregulates inhibitory cytokines CCL2 and VEGF, both of which have been implicated in tumor immune evasion [111,112,113]. Here, VEGFA is linked to neoplasm.